Tenderwize
Zurück zur Suche

Non-exclusive discount agreement for Propofol (N01AX10)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 672 days left·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Propofol (ATC-Code: N01AX10).

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

50 / 100

Komplexität

25 / 100

Risikofaktoren

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Enter into a non-exclusive discount agreement for the active ingredient Propofol (ATC N01AX10) for physician’s office supplies in Lower Saxony.
  • The agreement is under an open-house model: all qualified pharmaceutical entrepreneurs may join on identical terms, with no selection or negotiation.
Vollständige Zusammenfassung anzeigen

This is an open-house non-exclusive discount agreement (Rabattvertrag) for the active ingredient Propofol (ATC: N01AX10) for physician's office supplies (Sprechstundenbedarf) in Lower Saxony, Germany. The contracting authority is AOK Niedersachsen. The agreement is not a public procurement but a transparent open-house model where all qualified pharmaceutical entrepreneurs can join. The agreement period is from 01.09.2026 to 31.08.2028, with rolling entry possible on the first of each month. The first deadline for initial contracts is 28.07.2026. No estimated value is provided.

Risiken

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4(18) AMG or a consortium of such entrepreneurs.
  • Must have a registered seat in Germany, an EU member state, or an EEA state.
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs.

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0000

Non-exclusive discount agreement for Propofol (N01AX10)

This lot covers the conclusion of non-exclusive discount agreements for Propofol preparations in Lower Saxony under the open-house model. All interested pharmaceutical entrepreneurs can join with uniform conditions. No selection or competition.

SuppliesFrameworkEU fundedElectronic submission

Ort

DE929, Germany

Dauer

Aug 2026 - Aug 2028

Kategorie

Pharmaceutical products

Frist

Deadline Jun 27, 2028

Vergabedetails

Veröffentlichungsdatum
05 Jul 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
460781-2026

Ähnliche Ausschreibungen